TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Autor principal: | Afroza, Halima |
---|---|
Otros Autores: | Talukder, Mesbah |
Formato: | Tesis |
Lenguaje: | English |
Publicado: |
Brac University
2024
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/22075 |
Ejemplares similares
-
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
por: Islam, Nahidul
Publicado: (2023) -
Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
por: Tamanna, Shams Tahsin
Publicado: (2020) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
por: Islam, S.M. Zahidul
Publicado: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
por: Khandker, Tahia Anjum
Publicado: (2024) -
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
por: Akter, Anika
Publicado: (2022)